1198444
1206379
1206367
H3D Vision & Mission
Vision: To be the leading organisation for integrated drug discovery and development on the African continent Mission: Discover and develop innovative, life saving medicines For African patients Through excellence in interdisciplinary,...
R&D Environment
UCT offers a truly integrated environment for translational research in communicable and non communicable diseases afflicting people in Africa. It has both the infrastructure as well as numerous groups working on pre-clinical and clinical research...
H3D Facilities
Facilities H3D has state of the art laboratory equipment and access to modern instrumentation housed in the Department of Chemistry, the Department of Clinical Pharmacology and the Institute of Infectious Disease and Molecular Medicine (IDM) at UCT...
Home > Home

News

Monday, 21 October 2019
Medicines for Africans by Africans

Africa accounts for 15% of the global population and 25% of the global disease burden, yet the discovery and development of medicines that end up in Africa has historically only happened in the global north. It is time for the situation to change, says Professor Kelly Chibale, director and founder of the University of Cape Town’s (UCT) Drug Discovery and Development Centre, H3D.

Publication Date:
Fri, 18 Oct 2019 - 14:00
H3D Staff Member Awarded Young Researchers Award

Dr Vinayak Singh, H3D TB Biology, Drug Discovery and Development Centre, Faculty of Science was awarded the prestigious Young Researchers Award on 18th October 2019.

Read the full story here 

Publication Date:
Fri, 18 Oct 2019 - 12:00
Unlocking Africa's Health Innovation Potential

With African-led innovation in drug discovery lower than other continents, the government has a responsibility to address the barriers that stand in the way of creating an innovation-friendly environment.
 

Publication Date:
Tue, 15 Oct 2019 - 14:00
UCT Shares Expertise to Boost Search for New Drugs

Eight innovators from seven African countries have been announced as the inaugural awardees of the Grand Challenges (GC) Africa drug discovery programme. They will be involved in research that will advance the discovery of new drugs to prevent, treat and cure diseases endemic to Africa.

Publication Date:
Fri, 27 Sep 2019 - 14:00

Pages